WillItSurvive

China's largest dairy company, milk, infant formula, and ice cream, ~28-30% national share.

Hard to displace
Assessed 25 July 2026 · Evidence as of 25 July 2026
Strong structural protection; the business model survives ai pressure.
On the recordSince 25 July 2026 · Checkable from around August 27, 2026 · Every call on the record Checkpoint: Q2 2026 earnings release, key check on FY2026 revenue target of RMB 121.5 billion
The call

Yili sits in a stable two-player market with Mengniu, growing profit faster than revenue, while raw-milk oversupply and China's falling birth rate set the pace of its next decade.

Yili Group makes milk, yogurt, and baby formula across China through farms, factories, and stores. It is hard to replace because it controls about 30% of China's dairy market, has contracts with milk suppliers locked in for years, and runs 77 factories worldwide, but its main rival Mengniu is almost as big and just as entrenched. The one thing that could change the picture is if milk prices drop sharply or if fewer Chinese babies are born, which would hurt the baby formula business that makes Yili the most money right now.

Why
01
AI pressure: None apparent. AI shows up inside Yili as automation and supply-chain software, not as an outside force eating its dairy business. Could AI do the core job? Unlikely.
02
Bigger players: Mengniu Dairy. Mengniu holds a near-equal ~25-27% share and both firms compete hard on price as raw-milk oversupply squeezes the market. Could a giant copy it? No, they are blocked.
03
What protects it. Long-term raw-milk supply contracts, 77 production bases, deep distributor networks, and trust rebuilt after China's 2008 melamine scandal.
What would change this call
Yili quarterly gross margin trend through 2026-2027. Whether Mengniu price skirmishes are eroding pricing power despite flat revenue.
Infant-formula segment growth rate in coming quarterly reports. Whether China's shrinking birth cohort is capping Yili's fastest-growing, most profitable segment.
Debt/EBITDA trajectory following the RMB 45 billion note issuance. Whether leverage is creeping up without matching growth returns.
Key numbers
  • FY2025 revenue RMB 115.9B, net profit up 36.8% to RMB 11.6B (2026-04-29)
  • Infant formula revenue RMB 24.3B in 9M2025, up 13.7% (2025-09-30)
  • Raised RMB 45 billion via note issuance (2026-07-07)
Named risks
  • A serious food-safety incident, catastrophic but low-probability given post-2008 melamine scandal scrutiny. Severity: high
  • Raw-milk oversupply and Mengniu price skirmishes compressing gross margins despite flat revenue. Severity: medium
  • China's declining birth rate creates a long-term demand ceiling for the infant formula segment. Severity: medium
  • Leverage creep from RMB 45 billion July 2026 note issuance without offsetting revenue growth. Severity: medium
  • Ausnutria related-party transaction governance flashpoints given Yili's 60%+ controlling stake. Severity: low
Rivals, as read in July 2026
RivalDirectionEvidence
China Mengniu DairycontestingMengniu ~25-27% vs Yili ~28-30% national dairy share, recurring price skirmishes, 2024-2025
Wall's (Unilever China)gaining onEuromonitor 2026: Yili 30% vs Wall's 12% of China ice cream category
Feihe InternationalcontestingCompetes directly in premium infant formula segment in China, 2025-2026
Bright Dairy & FoodcontestingRegional rival strong in premium chilled/fresh milk in East China
Questions people ask
Is Yili Group profitable in 2026?
Yes. FY2025 net profit hit RMB 11.565 billion, up 36.82% year over year, even though revenue was roughly flat at RMB 115.931 billion, per results released April 29, 2026. Q1 2026 net profit rose a further 10.7% y/y.
Who owns Yili Group?
Yili is publicly traded on the Shanghai Stock Exchange (600887) with no controlling private parent. The Hohhot municipal government held roughly 8.5% as of 2024, making it a partly state-linked but broadly market-owned dairy giant.
Who is Yili's biggest competitor?
China Mengniu Dairy, also headquartered in Hohhot, is Yili's closest rival, holding an estimated 25-27% national dairy value share versus Yili's 28-30% as of 2024-2025, with recurring price skirmishes between the two.
Could AI replace Yili Group?
No. Yili's moat is physical and regulatory: raw-milk supply contracts, 77+ global production bases, post-2008-scandal infant-formula licensing, and distributor networks. Since December 2025 it uses Lenovo AI tools for productivity, not as a substitute for its core business.
Is Yili Group doing layoffs?
Not mass layoffs. Headcount edged down about 1% over two years, from 60,551 employees in 2023 to 59,923 in December 2025 per Revelio Labs, alongside a drop of 2,224 distributors in FY2024, consistent with automation-driven efficiency rather than cuts.
Is Yili's infant formula business growing?
Yes. Milk powder and infant nutrition revenue hit a record RMB 24.261 billion in the first nine months of 2025, up 13.74% year over year, with Yili describing itself as China's top-selling infant formula brand as of November 10, 2025.
Timeline
  • 2026-07-07Inner Mongolia Yili Industrial raised RMB 45 billion via note issuance
  • 2026-07-06Q1 2026 net profit reported up 10.7% year over year
  • 2026-05-20Launched global innovation initiative with University of Cambridge
  • 2026-05-15FY2025 results: revenue RMB 115.931B, net profit RMB 11.565B, up 36.82%
  • 2026-04-30Management set 2026 targets: revenue RMB 121.5B, profit RMB 13.6B
  • 2025-12-01Expanded AI partnership with Lenovo for VOC analytics and supply chain
  • 2025-11-109M2025 results: revenue RMB 90.564B, adjusted net profit topped RMB 10B
  • 2025-10-31Yili Industrial confirmed holding 60.18-60.2% controlling stake in Ausnutria
  • 2021-10-28Yili became largest shareholder of Ausnutria Dairy Corp with 34.33% stake
Revision history
25 July 2026
First assessed. Hard to displace. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources